Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000381

Drug Information
NameDoxazosin    
Synonyms1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin; Doxazosin [INN:BAN]; Prestwick0_000858; NCGC00018158-06; Lopac0_000474; HMS2090C20; 2-{4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-amine; D07874; Doxazosine; Prestwick3_000858; Doxazosinum [Latin]; DB00590; AC-11062; Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)-; Cardura-4; UK 33274; BSPBio_000875; 1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin; SPBio_002796; MolPort-001-684-491; IDI1_003732; CPD000097306; I06-1346; LS-110228; AC1L1FAT; 74191-85-8; Cardura-2; AKOS001681453; HMS1383E01; SAM002589981; AC1Q470P; Prestwick1_000858; BRD-A13188892-066-03-3; L000738; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[4-(1,4-benzodioxan-2-yl)carpiperazin-1-yl)]-6,7-dimethoxyquinazoline mesylate; C23H25N5O5; Oprea1_259518; Cardura-1; BPBio1_000963; Doxazosina; Prestwick2_000858; doxazosin; UK-33274; Doxazosine [French]; Doxazosina [Spanish]; C06970; 2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; Cardura XL (TN); Doxazosin (INN); Normothen; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone; CID3157; AC1Q4EXN; 2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-bis(methyloxy)quinazolin-4-amine; Doxazosinum; CHEMBL707; UNII-NW1291F1W8; ChemDiv2_005017; 77883-43-3 (mesylate); D9815_SIGMA; NCGC00089775-02; CHEBI:4708    
Trade NameCardura; Carduran    
CompanyPfizer Pharmaceuticals    
IndicationHypertensionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntihypertensive Agents    
CAS NumberCAS 74191-85-8
FormularC23H25N5O5    
PubChem Compound IDCID 3157.    
PubChem Substance IDSID 9184.    
ChEBI4708;    
SuperDrug ATC IDC02CA04;    
SuperDrug CAS ID074191858;    
TargetAlpha-1D adrenergic receptorAntagonist[2]
Ref 1Alpha blockers for the treatment of benign prostatic hyperplasia. Rev Urol. 2007 Fall;9(4):181-90. To Reference
Ref 2The role of combination medical therapy in benign prostatic hyperplasia. Int J Impot Res. 2008 Dec;20 Suppl 3:S33-43. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543